Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 6800 (110th)

Medicare Drugs for Seniors (MEDS) Act of 2008

referredUnited States· United States Congress· EN

Introduced

1 August 2008

Last action

1 August 2008 · Introduced

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Kucinich, Dennis J. [D-OH-10], Rep. DeFazio, Peter A. [D-OR-4], Rep. Lee, Barbara [D-CA-12], Rep. Conyers, John, Jr. [D-MI-13], Rep. Davis, Danny K. [D-IL-7], Rep. Abercrombie, Neil [D-HI-1], Rep. Jefferson, William J. [D-LA-2], Rep. Woolsey, Lynn C. [D-CA-6], Rep. Filner, Bob [D-CA-51], Rep. Hinchey, Maurice D. [D-NY-22], Rep. Jackson, Jesse L., Jr. [D-IL-2], Rep. Ellison, Keith [D-MN-5], Rep. Kaptur, Marcy [D-OH-9], Rep. Grijalva, Raúl M. [D-AZ-7], Sen. Hirono, Mazie K. [D-HI], Rep. Johnson, Eddie Bernice [D-TX-30], Rep. Cummings, Elijah E. [D-MD-7], Rep. Jackson Lee, Sheila [D-TX-18], Rep. Nadler, Jerrold [D-NY-12], Rep. Carson, André [D-IN-7], Sen. Baldwin, Tammy [D-WI]

Subjects

Healthcare

Source updated

14 August 2025

Healthcare

Summary

Medicare Drugs for Seniors (MEDS) Act of 2008 -Amends title XVIII (Medicare) of the Social Security Act to replace the current part D (Voluntary Prescription Drug Benefit Program) program, adopted by the Medicare Prescription Drug, Improvement and Modernization Act of 2003, with a revised prescription drug benefit program under a new part D (Prescription Medicine Benefit for the Aged and Disabled) for all Medicare beneficiaries. Provides for reductions in the price of prescription drugs for Medicare beneficiaries. Amends the Federal Food, Drug, and Cosmetic Act to: (1) revise requirements with respect to the commercial and personal importation of prescription drugs and the disposition of certain drugs denied admission; and (2) prescribe requirements with respect to Internet sales of prescription drugs. Provides that if any federal agency or any non-profit entity undertakes federally funded health care research and development, and is to convey or provide a patent or other exclusive right to use such research and development for a drug or other health care technology, such agency or entity shall not make such conveyance or provide such patent or other right until the recipient first agrees to a reasonable pricing agreement with the Secretary of Health and Human Services, or the Secretary determines that the public interest is served by a waiver of the reasonable pricing agreement. Sets forth Medigap transition requirements.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 1 August 2008

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  2. 1 August 2008

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 1 August 2008

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  4. 1 August 2008

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 1 August 2008

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 1 August 2008

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 1 August 2008

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 1 August 2008

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.